My primary research interests involve using population-based studies of genetic, circulating, and tumor biomarkers to investigate the role of inflammation and infections in carcinogenesis. I also have a more general interest in prostate cancer epidemiology and the identification of patient and tumor characteristics that could reduce overtreatment. Collaborating with research pathologists, urologists, medical oncologists, molecular biologists, immunologists, virologists, and bioinformaticists, I utilize data from a large Swedish population-based studies (CaPS and PCBaSe) and a Swedish randomized trial (SPCG-4), Swedish clinical cohorts, the Physicians’ Health Study, and the Health Professionals Follow-up Study.
ScD (Epidemiology), 2008, Harvard School of Public Health
MPH, 2004, University of Massachusetts – Amherst
BS (Zoology), 1997, University of Wisconsin – Madison
Instructor, Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School
Member, Cancer Epidemiology Program at Dana Farber/Harvard Cancer Center